Navigation Links
Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
Date:3/3/2008

DENVER, March 3 /PRNewswire/ -- Pharmatech, Inc., a Research Management Organization (RMO), has contracted with Systems Medicine LLC (SML), a subsidiary of Seattle-based Cell Therapeutics, Inc. (CTI), to provide research and site management services for their phase II open-label clinical study for patients with myxoid liposarcoma with a (12;16) translocation. The study is intended to assess the safety and efficacy of SML's experimental drug product, brostallicin. The trial will also be supported by the Sarcoma Foundation of America (SFA).

Pharmatech will manage this sarcoma trial using its innovative Just-In-Time(TM) (JIT) approach. This streamlined approach was created to increase enrollment in clinical trials for rare cancer disease indications with narrow patient populations. The study sponsor does not open the trial at the site level until a potential patient is identified through basic standard of care procedures, thus saving time, money, and effort for both the sites and the sponsors. Patient enrollment, through Just-In-Time, is further increased because a protocol can be rolled out to a large number of qualified Research Network sites with minimal expense of time and capital.

The SML trial allowed for the formation of a partnership between Pharmatech and the Sarcoma Foundation of America. The union of the two organizations helps create awareness for the Foundation's Sarcoma Patient Registry program. The Registry allows patients to call into the Foundation to sign up for participation in the Registry program. If they consent, then they are notified by the Foundation if a current or future trial fits their specific disease indications. Matthew Alsante, Executive Director, Sarcoma Foundation of America, states, "The collaboration allows for a superior coordination among key players in the clinical trial process. The patients come to the Foundation through our sophisticated Registry. The Foundation takes the incidence data from the Registry to communicate directly with the patients about the clinical trials available to them through partnerships with research management groups such as Pharmatech."

About Pharmatech, Inc.

Pharmatech, headquartered in Denver, Colorado, is a Research Management Organization (RMO) dedicated to the highest quality of clinical research, while protecting patient safety. Pharmatech provides services of a Site Management Organization (SMO) and a Contract Research Organization (CRO) with a focus in oncology clinical trials. Through organized research networks, the Company focuses on access to clinical trials for patients and clinical investigators. The Network model provides a foundation for the development and utilization of therapeutic products among sponsors, investigators, and patients. For more information about Pharmatech, please visit http://www.pharmatech.com.

About Systems Medicine LLC

Systems Medicine, LLC (SML), develops oncology products by integrating predictive cellular pharmacogenomics ("genomics") with world-class clinical and regulatory expertise. This allows SML to develop patient-selective therapies by defining the context of vulnerability of cancer and treating only those patients most likely to respond to specific drugs or drug combinations. For more information on SML and the products that SML has in development, please visit http://www.systems-medicine.com.

About the Sarcoma Foundation of America

The mission of the Sarcoma Foundation is to act as an advocate for increased research to find new and better therapies with which to treat patients with sarcoma. The Foundation has created a Sarcoma Patient Registry program that has the capability to match sarcoma patients into corresponding clinical trials. Please visit their website at http://www.curesarcoma.org for more information on the programs they have in place to help sarcoma patients.


'/>"/>
SOURCE Pharmatech, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Harris Corporation Teams with Cancer Treatment Services International to Advance Oncology Treatment
2. Michael J. Fox Foundation Awards Up to $3 Million to Industry Teams to Jumpstart Promising PD Drug Development
3. National Wrestling Coaches Association Teams Up With CSG/SportsCoatings(TM)
4. PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM)
5. PLC Systems Achieves Successful Early Conclusion of RenalGuard(TM) Pilot Safety Trial
6. Imaging Diagnostic Systems Updates PMA Filing Status for the New CT Laser Breast Imaging System
7. Imaging Diagnostic Systems CTLM Technology Presented at Congress of World Society for Breast Health
8. BD and PEPFAR Collaborate to Strengthen Laboratory Systems in Fight Against HIV/AIDS and TB
9. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
10. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
11. Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... in the ECG Cables And ECG Leadwires Market owing to ... devices. On the other hand, the Asia-Pacific ... rate during the forecast period. The market players ... plc ( Ireland ), Koninklijke Philips N.V. ( ... ( China ), held major share of the ...
(Date:12/2/2016)... Quantum Radiology,s Mobile Breast Center (QR MBC) ... to women at the workplace, thereby maximizing convenience and ... Air Lines and SunTrust Bank, and community health groups ... wellness initiatives. "I think it,s a great ... to have a mammogram without taking a large amount ...
(Date:12/2/2016)... , Dec. 2, 2016  Eli Lilly and Company ... guidance for 2017 and provide updated financial guidance for ... conduct a conference call on that day with the ... financial guidance. The conference call will begin ... public can access a live webcast of the conference ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... December 02, 2016 , ... Center for Autism and ... of those affected by autism spectrum disorder (ASD) and other developmental disabilities. The group, ... will give parents and other caregivers the opportunity to share stories and advice, seek ...
(Date:12/2/2016)... ... 02, 2016 , ... U.S. Surgeon General, Dr. Vivek Murthy, graces the cover ... he was inspired to practice medicine at an early age by his father, who ... making diagnoses and prescribing medicine,” he states. “It is about building relationships with people; ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... inspirational interview of two ostomy patients, standing as living proof that attitude and ... from digestive diseases and issues that spike around the holidays. This campaign will ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... More than ... and while 84 percent of parents report speaking with their child about sex related ... sexually transmitted diseases. , Mediaplanet is proud to announce the launch of its second ...
(Date:12/2/2016)... ... 2016 , ... CloudLIMS.com, a class-leading provider of Laboratory Management ... Lite helps biobanks, clinical, research and testing laboratories keep track of their biospecimens, ... is a faster and a more efficient product, allowing batch processing of data, ...
Breaking Medicine News(10 mins):